Publications by authors named "Tobias Ameismeier"

Article Synopsis
  • The study investigates the metabolic profiles in patients suspected of prostate cancer, focusing on differentiating clinically significant (csPCa) from clinically insignificant (ciPCa) and benign cases using serum samples.
  • A 22-metabolite panel was identified, which improves the discrimination of csPCa when combined with traditional clinical parameters like age and PSA levels, achieving an AUC of 0.84.
  • This research suggests that the identified metabolites, particularly ornithine and dimethylglycine, could serve as biomarkers to reduce unnecessary biopsies and identify potential treatment targets for prostate cancer.
View Article and Find Full Text PDF